It’s been a roller-coaster year for those hoping for new drugs to treat Alzheimer’s disease, a leading cause of death with rising treatment costs and no clear answer yet as to its cause.
Clearing proteins, such as amyloid and tau, was... Read more »
Bristol-Myers Squibb this week completed its acquisition of Celgene, a $74 billion deal that creates a pharmaceutical juggernaut. And all it took was the largest asset sale ever required by federal antitrust regulators.
As the Federal Trade Commission reviewed Bristol’s (NYSE:... Read more »
Drug pricing debates and uncertainty associated with Brexit are the issues most likely to keep biopharmaceutical executives awake at night. Nevertheless, senior figures remain optimistic about the industry’s prospects in 2020. These are among the major findings of a survey of... Read more »
AstraZeneca says it will establish centers for drug research and artificial intelligence development in China. The pharmaceutical giant has also set up a $1 billion fund to foster biotech innovation in that country.
The doors have opened at a GE Healthcare-supported open-access lab for startups at AstraZeneca’s former global center for oncology research and development at Alderley Park, the largest bioscience research campus in the UK.
Five years ago, the big tech incubator Y Combinator started to welcome life sciences companies into its sizable startup classes, which had previously nurtured entrepreneurs in information technology almost exclusively.
That opening to biotech startups in 2014 was controversial at the... Read more »
One Texas-based healthcare software business has acquired another in an all-cash deal worth $36.5 million, the companies announced late Monday.
Co-founder of LiveOak Venture Partners
Senior vice president of global technology strategies for the Greater Austin Chamber of Commerce
Chairman & CEO, Asuragen
CEO of Aeglea BioTherapeutics
Vice president, chief strategy and operating officer of the Texas Medical Center
CEO and President of Bluegrass Vascular Technologies
CEO and founder of Cancer Insight
Vice Chancellor, University of Houston
Founder and CEO, Dallas Entrepreneur Center
Former CEO, Pike Powers Group; Entrepreneur
President, University of Texas Medical Branch in Galveston